Entrada Therapeutics TRDA
NASDAQ TRDA
$4.65 -0.34 (-6.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) EV to EBIT (2024 - 2025)

Updated

Entrada Therapeutics' (TRDA) EV to EBIT stood at 66.98 in Q1 2025, up 289.8% from 17.18 a year earlier and up 474.1% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) EV to EBIT (2024 - 2025) Analysis & Trends

On a TTM basis, Entrada Therapeutics' EV to EBIT came in at -21.75 as of Mar 31, 2025; for FY2024, it was 11.67.

  • Per Business Quant, the preceding three quarters came in at 11.67 (Q4 2024), 8.99 (Q3 2024) and 3.69 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Entrada Therapeutics 195.28 Mn -164.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 66.98
Dec 31, 2024 11.67
Sep 30, 2024 8.99
Jun 30, 2024 3.69
Mar 31, 2024 17.18
API Access

Entrada Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=TRDA&period=max&api_key=YOUR_API_KEY